Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Estimating the return on investment in disease management programs using a pre-post analysis.

Donald Fetterolf1, David Wennberg, Andrea Devries

  • 1Highmark, Inc., Pittsburgh, Pennsylvania 15222, USA. donald.fetterolf@highmark.com

Disease Management : DM
|March 24, 2004
PubMed
Summary

Disease management programs' cost-effectiveness is questioned due to flawed "pre-post" analysis. This paper highlights methodological issues leading to inaccurate financial assessments in healthcare programs.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Postmarketing safety surveillance for GSK's AS01<sub>E</sub>-adjuvanted respiratory syncytial virus prefusion F protein-based vaccine in the USA: protocol for a non-interventional postauthorisation safety study.

BMJ open·2026
Same author

Post-authorization safety study to assess the risk of diabetic ketoacidosis among type 2 diabetes mellitus patients treated with ertugliflozin compared to patients treated with other antihyperglycaemic agents in a Medicare and Medicaid population.

Diabetic medicine : a journal of the British Diabetic Association·2026
Same author

Trends in delivery of comprehensive medication reviews by race and ethnicity, 2013-2021.

Journal of managed care & specialty pharmacy·2025
Same author

Lecanemab Therapy Use Patterns for Alzheimer's Disease Among Early Initiators in a Large National Health Plan.

Journal of the American Geriatrics Society·2025
Same author

Cardiovascular Events in Individuals Treated With Sulfonylureas or Dipeptidyl Peptidase 4 Inhibitors.

JAMA network open·2025
Same author

Association of Participation in Medicare's Oncology Care Model With Spending, Utilization, and Quality Outcomes Among Commercially Insured and Medicare Advantage Members.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2024

Area of Science:

  • Health Services Research
  • Medical Economics

Background:

  • Disease management programs have grown in popularity over the last 5-10 years.
  • Rising healthcare costs prompt scrutiny of program cost-effectiveness.
  • Concerns exist regarding the methodologies used to evaluate these programs.

Purpose of the Study:

  • To critically evaluate the "pre-post" methodology in disease management program analysis.
  • To identify potential flaws in "pre-post" approaches that may skew results.
  • To ensure accurate financial outcome assessments for healthcare management initiatives.

Main Methods:

  • Discussion of "pre-post" methodology limitations.
  • Analysis of how flawed approaches yield spurious results.
  • Presentation of a checklist for operational staff.

Related Experiment Videos

Main Results:

  • "Pre-post" analysis can lead to incorrect financial assessments.
  • Methodological flaws can misrepresent the true cost-effectiveness of disease management programs.
  • Specific areas prone to spurious results are identified.

Conclusions:

  • The "pre-post" methodology requires careful consideration in disease management program evaluations.
  • Accurate assessment is crucial for justifying the financial viability of healthcare programs.
  • The paper provides tools to improve the rigor of program analysis.